Compassionate useMitochondrial Peptide
Compound 61571
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061571
Risk Class
MODERATE
Last Audit
Apr 15, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61571 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in compassionate use with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061571 with updates logged 2108-04-15.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61571Mitochondrial Peptide Program 61571
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061571
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61571